Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax Plummets: Covid Vaccine Sales Widely Lag On Unexpected Losses, Slashed Guidance
05:00pm, Monday, 08'th Aug 2022
Novavax widely missed second-quarter forecasts Tuesday, leading the Covid vaccine maker to slash its guidance and NVAX stock to crash. The post Novavax Plummets: Covid Vaccine Sales Widely Lag On Unex
Novavax slashes sales guidance in half, stock plunges 30%
04:59pm, Monday, 08'th Aug 2022
Novavax Inc. executives slashed their annual sales guidance in half on Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading.
Novavax cuts 2022 revenue guidance in half, stock tanks in after-hours trading
04:47pm, Monday, 08'th Aug 2022Why Novavax Stock Is Falling Monday
03:33pm, Monday, 08'th Aug 2022
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.
Is Novavax's latest wins about to help it shed the meme tag when it reports earnings?
04:05pm, Friday, 05'th Aug 2022
Novavax, Inc. (NASDAQ:NVAX) is not the usual meme stock akin to GameStop and AMC. However, it has often been at the center of retail investor interest at the slightest of the news.
Why Novavax Stock Jumped on Tuesday
04:40pm, Tuesday, 26'th Jul 2022
The biotech company got good news about its COVID-19 vaccine.
Novavax's COVID-19 vaccine is authorized for teens in Australia and Japan
08:44am, Tuesday, 26'th Jul 2022
Novavax Inc. NVAX, +1.20% said Tuesday that its COVID-19 vaccine received authorization in Australia and Japan for teens. Both authorizations are for adolescents between the ages of 12 and 17 years ol
2022 Roundtable: Our Favorite Picks Right Now
10:00am, Sunday, 24'th Jul 2022
Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.
Novavax CEO on COVID vaccine approval and next steps
12:00am, Saturday, 23'rd Jul 2022
Novavax CEO Stanley Erck remarks on the FDA's Covid vaccine approval, and the potential next steps. Segment originally aired on July 21, 2022.
Why Novavax Stock Is Down More Than 7% Today
02:34pm, Friday, 22'nd Jul 2022
The market has lost interest in the race for COVID-19 vaccines, perhaps understandably so.
Is This Vaccine Stock a Buy After Big News?
06:45am, Friday, 22'nd Jul 2022
Two years after the onset of COVID-19 in the U.S., a new vaccine is coming to market -- who will it help?
Novavax COVID-19 vaccine will be available ‘next week,' CEO says
01:39pm, Thursday, 21'st Jul 2022
Novavax CEO Stan Erck joins Yahoo Finance Live medical reporter Anjalee Khemlani to discuss the CDC recommending Novavax's COVID-19 vaccine for adults, COVID vaccine distribution, the vaccine demand,
Is It Too Late to Buy Novavax Stock?
11:07am, Thursday, 21'st Jul 2022
It isn't going to experience meteoric growth, but buying it could still pay off.
CDC Recommends Novavax, the 4th COVID Vaccine to Be Authorized
03:59pm, Wednesday, 20'th Jul 2022
The CDC's director signed off late Tuesday, making Novavax available to adults who haven't been vaccinated yet.
Here's How Novavax Stock Could Rally Through 2023
11:23am, Wednesday, 20'th Jul 2022
Its vaccine might be more effective as a booster than the other options.
